Anais Do 5º Encontro Brasileiro Para Inovação Terapêutica 2017
DOI: 10.17648/ebit-2017-85606
|View full text |Cite
|
Sign up to set email alerts
|

Inovações Tecnológicas No Uso Do Praziquantel Para O Tratamento Daesquistossomose

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…PZQ is about the only drug available for the treatment of schistosomiasis. Another drug, oxamniquine (OXA), is less widely used since it is not effective against two of the main causes of schistosomiasis, S. japonicum and S. haematobium although it is effective against S. mansoni [13]. Prior to the discovery of these two drugs, a range of trivalent antimony compounds were used to treat the disease.…”
Section: Introductionmentioning
confidence: 99%
“…PZQ is about the only drug available for the treatment of schistosomiasis. Another drug, oxamniquine (OXA), is less widely used since it is not effective against two of the main causes of schistosomiasis, S. japonicum and S. haematobium although it is effective against S. mansoni [13]. Prior to the discovery of these two drugs, a range of trivalent antimony compounds were used to treat the disease.…”
Section: Introductionmentioning
confidence: 99%